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Summary. The cellular distribution of Na+, K+-ATPase 
subunit isoforms was mapped in the secretory epithelium 
of the human prostate gland by immunostaining with 
antibodies to the a and B subunit isoforms of the 
enzyme. Immunolabeling of the a l ,  B 1  and B2 isoforms 
was observed in the apical and lateral plasma membrane 
domains of prostatic epithelial cells in contrast to human 
kidney where the al and B 1  isoforms of Na+, K+- 
ATPase were localized in the basolateral membrane of 
both proximal and dista1 convoluted tubules. Using 
immunohistochemistry and PCR we found no evidence 
of Na+, K+-ATPase a 2  and a 3  isoform expression 
suggesting that prostatic Na+, K+-ATPase consists of 
allí31 and allí32 isozymes. Our immunohistochemical 
findings are consistent with previously proposed models 
placing prostatic Na+, K+-ATPase in the apical plasma 
membrane domain. Abundant expression of Na+, K+- 
ATPase in epithelial cells lining tubulo-alveoli in the 
human prostate gland confirms previous conclusions 
drawn from biochemical,  pharmacological and 
physiological data and provides further evidence for the 
critica1 role of this enzyme in prostatic cell physiology 
and ion homeostasis. Na+, K+-ATPase most likely 
maintains an inwardly directed Na+ gradient essential for 
nutrient uptake and active citrate secretion by prostatic 
epithelial cells. Na+, K+-ATPase may also regulate 
lumenal Na+ and K+, major counter-ions for citrate. 
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lntroduction 
It is established that an important physiological 
function of the prostate gland i s  the synthesis,  
accumulation and secretion of citrate (e.g. Kavanagh, 
1985; Farnsworth, 1990; Costello and Franklin, 1997). 
However, relatively little is known about some basic 
aspects of prostate cell physiology. In particular, the 
membrane transport mechanisms involved in the 
formation and secretion of prostatic fluid are not fully 
understood. It is well known that citrate secretion 
depends upon the accumulation of the amino acid 
aspartate, an important precursor that is  further 
metabolized by transamination to oxaloacetate for citrate 
synthesis (Franklin and Costello, 1984). Work by 
Franklin et al., (1990) has shown that the concentration 
of aspartate is up to 43 times higher in prostate epithelial 
cells than serum. 7 k o  kinetically distinct Na+-dependent 
aspartate transport systems maintain this large 
concentration gradient for aspartate. Continuous supply 
of aspartate to the prostate is essential for rapid secretion 
of citrate and ensures high-capacity aspartate uptake 
from plasma and prostatic secretory fluid. These Na+- 
dependent aspartate transporters are inhibited in vitro 
when steroidal Na+, K+-ATPase inhibitors (e.g. ouabain) 
are present indicating the absolute dependency of 
aspartate accumulation, and consequently citrate 
secretion, on an inward Na+ gradient generated and 
maintained by the plasma membrane Na+, K+-ATPase. 
Thus, the available data supports a model of citrate 
secretion dependent on the activity of Na+, K+-ATPase. 
The active uptake of severa1 other amino acids and 
sugars by the prostate gland and the activity of the Na+, 
K+-ATPase are androgen dependent (Farnsworth, 1970, 
1972, 1990). Despite the large body of pharmacological, 
biochemical and anecdotal evidence supporting its 
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function in the prostate (Farnsworth, 1993), however, the 
precise cellular distribution and patterns of isoform 
expression of Na+, K+-ATPase have remained 
unexplored. Accordingly, the goals of the present 
investigation were to determine the cell type specific and 
subcellular expression pattern of Na+, K+-ATPase 
isoforms in the adult human prostate gland. 
Materials and methods 
Prostate tissues were obtained from 16 patients aged 
between 55 and 78  years undergoing transurethral 
resection of the prostate for benign prostatic hyperplasia 
(BPH). Al1 prostate samples were obtained from patients 
of Greenwich District Hospital (Greenwich, UK), St. 
Thomas's Hospital (King's College London, UK) and 
East Surrey Hospital (Redhill, UK). Local Ethics 
Committee approval was obtained at the outset and 
proper institutional guidelines were followed throughout 
this study. Samples were fixed in neutral buffered 
formalin for  at least 4 8  hours and subsequently 
embedded in paraffin wax prior to sectioning at 5-7 pm 
and mounting on Vectabond glass  slides (Vector 
Laboratories, Peterborough, UK). Sections of human 
kidney, obtained from necropsies were used as positive 
controls for the detection of Na+, K+-ATPase expression 
in basolateral membranes of renal tubules. 
Chemicals 
Al1 chemicals were molecular biology grade and 
purchased from SigmaIAldrich and Sigma Biosciences 
(Poole, Dorset, UK). Peroxidase kits were purchased 
from SigmaIAldrich and Vector Laboratories 
(Peterborough, UK). Molecular biology and PCR kits 
were obtained from Advanced Biotechnologies (Epsom, 
Surrey, UK). PCR primers were synthesized by 
Amersham-Pharmacia (Bucks, UK), and Sigma-Genosys 
(Dorset, UK). 
Panel of isoform specific antibodies 
Immunohistochemical studies were conducted 
utilizing a panel of well-characterized monoclonal and 
polyclonal isoform specific antibodies against known 
Na+, K+-ATPase isoforms (see Table 1 for codes, 
sources, dilutions and references). In addition, a 
monoclonal antibody to prostate specific antigen (Vector 
Laboratories/Novocastra, Peterborough, UK) was used 
as phenotypic marker for the prostatic epithelium (Fig. 
lB,C). 
a antibodies 
(1) Monoclonal antibodies 6F and a620 against the 
a l - subun i t  isoform of the Na+, K+-ATPase were 
obtained from Dr. D.M. Fambrough (Biology 
Department, Johns Hopkins University, Baltimore, USA; 
Takeyasu et al., 1988) and Dr. Michael Caplan (Yale 
University, New Haven, U.S.A.; Gottardi and Caplan, 
1993a,b) respectively. Antibody 6F was also purchased 
from the Developmental Studies Hybridoma Bank 
(University of Iowa, Iowa City, USA). Antibodies 6F 
and a620 have been demonstrated to exhibit a broad 
mammalian species specificity, which includes binding 
to epitopes of the human al subunit. (2) A commercial 
monoclonal antibody specific for the al  isoform 
(designated UBIa1)  was purchased from Upstate 
Biotechnology Inc. (Lake Placid, New York, USA). This 
antibody originally developed by Dr. Michael Caplan 
(Gottardi and Caplan, 1993a,b) was used at a final titre 
of 1:100. (3) Monoclonal antibody McB2 against the a 2  
subunit of the Na+, K+-ATPase was a gift from Dr. K.J. 
Sweadner (Massachusetts General Hospital, Harvard 
Medical School, Boston, USA; Urayama et al., 1989). 
McB2 was raised against Na+, K+-ATPase derived from 
rat brainstem axolemma and is specific for the a 2  
subunit, and not the B subunit or any other isozyme of 
the Na+, K+-ATPase (Urayama et al., 1989). McB2 has 
been mapped to the peptide epitope sequence 
GREYSPAATTAENG near the N terminus of the a 2  
subunit isoform (Peng et al., 1997). McB2 cross reacts 
with many avian and mammalian species including 
human and recognizes a 3  subunits of the Na+, K+- 
ATPase whether native, denatured or fixed. (4) 
Monoclonal antibody XVIF9-G10 against the a 3  
isoform of the Na+, K+-ATPase originally developed by 
Dr. K.P. Campbell (University of Iowa, Iowa City, USA; 
Table 1. lsoform specific antibodies used in this study to detect isoforms of the Na+, K+-ATPase subunits in immunohistochemistry. 
ANTIBODY ISOFORM WORKlNG DlLUTlON SOURCE REFERENCE 
6 F  (Monoclonal) al Neat Supemaiant Developmental Studies Hybridoma Bank Takeyasu et al., 1988 
a620* (Polyclonal) a l  1:lOO M. Caplan Gottardi and Caplan, 1993a,b 
UBlal (Monoclonal) al 1:lOO Upstate Biotechnology Gottardi and Caplan, 1993a,b 
McB2 (Monoclonal) a2 Neat Supernatant K.J. Sweadner Urayama et al., 1989 
XVIF9GlO (Monoclonal) a3 Neat Supernatant K.J. Sweadner Arysiarkhova and Sweadner, 1996; 
Peng et al., 1997 
SpETB1 (Polyclonal) B 1 1 :600 P. Martin-Vasallo Gonzalez-Mattinez et al., 1994 
SpETB2 (Polyclonal) B2 1 :600 P. Mattin-Vasallo Gonzalez-Mattinez et al., 1994 
*: used as cocktail in most experiments. 
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Peng et al., 1997) was a gift from Dr. K.J. Sweadner. 
XVIF9-G10 was used at a concentration of 3 , ~ ~ . m l - l  or 
as neat hybridoma supernatant. XVIF9-G10 localizes the 
Na+, K+-ATPase in a variety of mammalian species 
expressing the a 3  isoform. 
B antibodies 
Polyclonal isoform specific antibodies against the B 1  
and 52 subunits of Na+, K+-ATPase (antisera SpETBl 
and SpETB2, respectively) were developed in rabbits 
against fusion proteins of human 51  and B2 isoforms 
produced by over-expression in E.coli (González- 
Martínez et al., 1994). The 5-specific antisera were both 
diluted 1:600 for immunohistochemistry. These 
antibodies are highly specific for B isoforms and have 
been used successfully in determining the polarized 
localization of Na+, K+-ATPase in the apical membrane 
of the rat inner ear and choroid plexus (González- 
Martínez et al., 1994). 
Secondary antibodies 
An affinity isolated anti-mouse IgG (whole 
molecule) peroxidase conjugate developed in goat was 
purchased from Sigma (product A-4416) and used at a 
working dilution ranging between 1:1000 and 1:5000. 
An affinity isolated anti-rabbit IgG (whole molecule) 
peroxidase conjugate developed in goat was purchased 
from Sigma (product A-0545) and used at a working 
dilution ranging between 1:1000 and 1:10000. Both 
antibodies were pre-adsorbed with human IgG to ensure 
minimal cross-reactivity with human proteins in tissue 
sections. 
Immunohistochemistry 
Paraffin embedded prostate sections (5-7 pm) were 
cleared in 100% xylene for 10 minutes before immersing 
in 100% ethanol. Immersing the sections in 3% (v:v) 
H202 in absolute methanol for a minimum of 1 hour 
quenched endogenous peroxidase activity. The sections 
were then briefly taken to water and equilibrated in 
phosphate buffered saline (PBS) consisting of 0.01M 
sodium and potassium phosphate buffer (pH 7.4), 
containing 27mM potassium chloride and 0.137M 
sodium chloride for 5 minutes before antigen retrieval. 
Two antigen retrieval techniques were compared and 
utilized in this study. The first involved microwave 
heating of prostate sections in a solution of 1-2% zinc 
sulfate for 10  minutes (Shi et al., 1991). The second 
antigen retrieval technique used involved incubating 
prostate sections in a 1% solution of sodium dodecyl 
sulfate (SDS) in PBS for 5-10 minutes (Brown et al., 
1996). This technique gave superior results to microwave 
heating and was adopted as the preferred method of 
antigen retrieval. Prostate sections were immersed in 
10% (v:v) normal goat serum (NGS) in PBS for at least 
one hour at room temperature to block non-specific 
antibody binding. Thereafter excess serum was removed 
and prostate sections were incubated overnight at 4 "C 
with the primary monoclonal and polyclonal antibodies 
diluted in PBS containing 1-2% NGS (see Table 1). 
Subsequently the sections were rinsed 3x15 min in PBS 
before incubation with the secondary peroxidase 
conjugated antibodies diluted in PBS containing 3-5% 
NGS for 2 hr at room temperature. Prostate sections 
were rinsed (4x15 min) in PBS before developing the 
peroxidase product. Sigma FAST DAB (3,3'- 
Diaminobenzidine tetrahydrochloride) tablets or 
Vector Laboratories DAB were used in immunohisto- 
chemistry as the precipitating agent in this reaction. 
For some antibodies, particularly SpETBl and 
SpETB2, which exhibited extraordinary affinities 
for their respective antigens in the prostate sections, 
the Vector Laboratories DAB substrate kit for 
peroxidase (SK-4100) was preferred. Sect ions 
were lightly stained with haematoxylin following 
immunohistochemistry to reveal nuclei and mounted in 
DPX . 
Microscopy 
Slides were viewed and photographed using a Zeiss 
Table 2. Sequences of primers used for the speciiic amplication of a isoforms. Isofom specific primers were specially designed to anneal to areas 
that show minimal homology and thus amplify only one isoform under high stringency PCR conditions (Mobasheri et al., 1997). Before primer synthesis, 
al1 primer sequences were checked by submitting the sequences using BLAST to NCBl (http:liwww.ncbi.nlm.nih.gov/). In al1 cases the isoform specific 
primers retrieved cDNA sequences of the specific isoform. Also shown is the sequence for the gene 0 actin used as an interna1 PCR control. 
PRIMER SPEClFlClTY SEQUENCE EXPECTED PRODUCT 
AND DlRECTlON ( b ~ )  
a l  Forward 5' CTTAGCClTGATGAACTTCATC 3' 349 
a l  Reverse 5' TGATTACAACGGCTGATAGCAC 3' 349 
a2 Forward 5' CAGAAGGAGAAGGAACTG 3' 279 
a2 Reverse 5' TTGTCGTTGGATGGTTCATCCTC 3' 279 
a3 Forward 5' ATGACCTCAAGAAGGAGGTGGC 3' 307 
a3 Reverse 5' GTTGTCAGCAGAGGGGT 3' 307 
a4 Forward 5' TAACCTTGGAAGAGCTGAGCA 3' 494 
a4 Reverse 5' TCClTGTGCAGAGATAAGCC 3' 494 
B-acün Forward 5' TTCAACTCCATCATGAAGTGTGACGTG 3' 310 
0-actin Reverse 5' CTAAGTCATAGTCCGCCTAGAAGCAlT 3' 31 0 
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Axioskop microscope fitted with an MC 100 SPOT 35 
mm microscope camera with automatic exposure 
control. Kodak TMAX professional black and white film 
and Kodak Ektachrome 64 Tungsten color film were 
used throughout this study. 
Human prostate cDNA library 
A Human prostate 5'-stretch plus cDNA library was 
purchased from Clontech laboratories (Palo Alto, 
California, USA). The cDNA library was prepared from 
whole prostates of 10 caucasians, aged between 14-60 
with healthy prostates. The library was amplified once 
in XL-1-Blue and was found to contain 3 . 0 ~ 1 0 ~  
independent clones with an average cDNA size of 1.7kb. 
Polymerase Chain Reaction (PCR) 
PCR was employed to confirm data obtained using 
the a isoform specific monoclonal antibodies. 
Oligonucleotide primers, complementary to nucleotide 
sequences in the known human a isoform genes ( a l ,  a2, 
a 3  and a 4 )  were synthesized (Amersham-Pharmacia, 
UK and Sigma-Genosys, UK). The sequences for the 
isoform specific primers used are shown in Tables 2 and 
3 (Mobasheri et al., 1997; Stengelin and Hoffman, 
1997). The Reddy-Load PCR Master Mix (Advanced 
Biotechnologies, Surrey, UK) was chosen as the PCR 
reagent of choice due to the high fidelity and efficiency 
of its constituent Taq DNA polymerase. PCR was carried 
out for 40 cycles. PCR products were loaded directly 
onto 1% horizontal agarose gels buffered with Tris- 
borate EDTA (TBE), separated electrophoretically over 
45 min and stained for 15 min with ethidium bromide 
before visualization under UV light. In cases where 
high-resolution electrophoretic separation was desired 
12% TBE buffered polyacrylamide gels were used 
instead of agarose gels.  Gels were photographed 
digitally using a Pulnix digital video camera equipped 
with a dedicated macro-lens attached to an IBM PC 
running DT-Acquire (Data Translation, Wokingham, 
UK) and Scion Image analysis software (Scion 
Corporation, USA). 
Results 
Al1 the prostate tissue used in this study was 
obtained from normal subjects but the majority of the 
tissues exhibited classic morphological features of BPH 
(Fig. 1A). The tubulo-alveoli of the prostate gland varied 
enormously in size and form. The appeared as alveoli, as 
alveoli with branches, tubes or tubes with branches. 
Many of the individual secretory glands appeared 
distended or collapsed. The epithelial cell layer consisted 
mainly of columnar cells, although some basa1 cells 
were present. For this reason, the epithelium is often 
classified as pseudostratified columnar. Many epithelial 
cells possessed apical cytoplasmic protrusions that 
appeared to break off into the lumen. The stroma 
surrounding the glands consisted of smooth muscle cells, 
neuroendocrine cells and blood vessels (blood vessels 
not visible in Fig. 1A). Immunohistochemical studies 
using an antibody to prostate specific antigen (PSA) 
revealed abundant expression in the prostatic epithelium. 
(Fig. 1 A,B). 
The most striking feature of the immunohisto- 
chemical data presented in this study was that Na+, K+- 
ATPase a l ,  R 1  and B2 isoforms were abundantly 
expressed in the prostatic epithelial cells (Figs. 2-4). In 
contrast, antibodies specific for the a 2  and a 3  isoforms 
(McB2 and XVIF9-G10, respectively) gave no 
immunostaining in paraffin sections whether or not 
subjected to antigen retrieval (Fig. 5). The al isoform of 
Na+, K+-ATPase was found in the epithelial cell layer of 
prostate tubulo-alveoli varying in size and shape. Data 
shown in Figs. 2, 3 (panels A,B) summarize the results 
of experiments in which a cocktail of two al specific 
monoclonal antibodies was used on prostate sections and 
human kidney sections (used as controls). Although 
some staining was observed in vascular smooth muscle 
(Fig. 2 panels A-C) the strongest immunostaining was 
observed in epithelial cells (Fig. 2 panels A-C). The al 
immunostaining in the epithelial cell layer was clearly 
apical and lateral in most tubulo-alveoli examined. 
Table 3. Sequences of alternative primers for amplification of Na+, K+-ATPase a isoforms and the B isoforms (Stenelin and Hoffman, 1997). 
PRIMARY SPEClFlClTY SEQUENCE 
AND DlRECTlON 
EXPECTEDPRODUCT 
ibp) 
a l  Forward 
a l  Reverse 
a2 Forward 
a2 Reverse 
a3 Forward 
a3 Reverse 
B1 Forward 
B1 Reverse 
B2 Forward 
B2 Reverse 
B3 Forward 
03 Reverse 
5' ATGGGGAAGGGGGTGGACGTGATAA 3' 
5' TCTCACCATITCGAATCACAAGGGCl-r 3' 
5' GGCGGCAAGAAGAAACAGAAGGAG 3' 
5' TGGGGCTCCGACTCTCCTGTTAAG 3' 
5' ATGGAGATACACGACAAGAAAGATGACAAGGAC 3' 
5'CCCGACCACCACCTCCTCAGCGTCACCTGCAT3' 
5' ATGGCCCGCGGGAAAGCCAAGGAGGAGGGCAGC 3' 
5' CTITCGCTCTCCTCGTCATGATAAAGTCTCC 3' 
5' ATGGAGTCCTCAACTACCCCAAACTGGCCT 3' 
5' TCAGGlllTGlTGATGCGGAGmGAAGGCCAC 3' 
SAAGAAGTCCCTCAACCAGAGCCTGGC3' 
5' TGCAACATAAACTGGACCClTCTGT 3' 
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Intense peroxidase activity was detected in the apical 
"domes" and lateral membranes of the epithelial cells. In 
contrast in human kidney sections the al and B 1  subunit 
isoforms were detected exclusively in the basolateral 
domain of convoluted tubules (Fig. 3 panels C, D). 
Negative controls consisting of prostate sections 
incubated exclusively with peroxidase labeled secondary 
antibodies (omitting the primary monoclonal) gave no 
discernible immunoreactivity and the background 
staining was negligible (Fig. 2 panel D). Experiments in 
which antigen retrieval was not performed prior to 
routine immunolabeling produced significantly lower 
immunostaining (results not shown). From a 
methodological viewpoint, the results obtained following 
SDS antigen retrieval are consistent with previous 
reports of increased al isoform detection in the kidney 
and cultured MDCK cells (Brown et al., 1996). 
Prostate sections incubated with the 8 isoform 
specific polyclonal antisera gave intense immunostaining 
of both B 1  and 82. As with the pattern of al expression, 
both B 1  and B2 were expressed by the epithelial cells 
(Fig. 4 panels A, C) and concentrated in the apical and 
lateral membranes of the cells (Fig. 4 panels B,D). 
Portions of the smooth muscle layer were immuno- 
Flg. 1. Low (A) and high (B) power immuno- 
histochemical digital photomicrographs showing 
expression of prostate specific antigen (PSA) in the 
prostatic epithelium. The majority of sections 
examined exhibited classic morphological features of 
benign prostatic hyperplasia (BPH) (panel A). A, 
x 400; B, x 1,000 
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Flg. 2. lmmunolocalization of Na+, K+-ATPase al isoform in the human prostate gland. A. Ught micrograph demonstrating abundant expression in 
epithelial cells (ECL) and to a lesser extent in the smooth muscle cells (SM). The most abundant immunostaining is related to the apical membranes 
and significanly enhanced in a subset of cells. Expression of the al isoform appears more pronounced in apical and lateral membranes of epithelial 
cells of hyperplastic nodules (B) but is less marked in non-hyperplastic zones of iarger tubulo-alvedi (C). Sections incubated without primary antibody 
(secondary peroxidase-conjugated antibody only) produced no staining and background staining is negligible (D). PS: prostatic secretion; L: lumen; 
CT: connective tissue; ECECL: epithelial cell layer; Px Ab: peroxidase antibody; cec: columnar epithelial cell; bc: basa1 cell. x 400 
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reactive, particularly for B2. The apical and lateral 
membrane domains of the epithelial cells demonstrated 
by far the strongest peroxidase staining compared to 
basolateral surfaces. Overall there was no significant 
cellular heterogeneity in Nat, Kt-ATPase expression in 
ducts or glands. The fact that Nat, Kt-Amase localized 
to different membrane domains in the prostate and 
kidney indicated differential plasma membrane sorting 
and targeting in these two tissues. 
PCR using Na+, K+-ATPase a isoform specific 
primer pairs  was used as  described previously 
(Mobasheri et al., 1997; Stengelin and Hoffman, 1997). 
Specific DNA fragments corresponding to the al  
isoform were amplified from prostate cDNA libraries 
pooled from subjects with normal prostates (Fig. 6A,B). 
The 349 bp and 530 bp DNA fragments amplified using 
al specific primer sets confirmed that normal human 
prostate contained mRNA only for the al subunit of 
Na+, Kt-Amase. Absence of DNA fragments from lanes 
corresponding to a2,  a3 and a 4  confirmed the absence 
of mRNA encoding these polypeptides (Fig. 6B). PCR 
products corresponding to B 1  and 82  were detected but 
Flg. 3. Expression of the al isoform of Na+, K+-ATPase in dlfferent rnernbrane dornains of human prostate and kidney sedons. A and B. Low and high 
power lrnrnunohistochernical photornicrographs of human prostate stained for the al -subunit using rnonoclonal antibodies 8Fla620 shwing intense 
staining of the apical (large black arrows) and lateral (white arrows) domains of epithelial cells. lmmunohistochemical preparations of human kidney 
localized the al isoforrn of Na+, K+-ATPase to badateral rnernbranes of cells (black arrows in panel D) lining the convoluted tubules (panels C and D). 
A, C, x 400; 8, D, x 1,000 
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B3 expression was not detected (Fig. 6A). 
Discussion 
Nat, K+-AlTase is an integral membrane enzyme 
responsible for regulating intracellular Na+ and K+ 
concentrations using ATP as an energy source 
(Mobasheri et al, 2000). It maintains a low intracellular 
Na+:Kt ratio in face of an inward concentration gradient 
for Na+ and an outward gradient for K+ (see Sweadner, 
1989, 1995). The enzyme is composed of a 110 kDa 
catalytic a subunit and a 35 kDa regulatory B subunit 
(45-55 kDa including N-linked sugars) (Sweadner, 
1995). The a subunit contains the binding sites for Nat, 
K+, ATP and cardiac glycosides, a class of steroid 
compounds, which serve as specific inhibitors of Na+, 
K+-ATPase. The B subunit is required for biogenesis 
(Ueno et al., 1997) and activity of the enzyme complex 
which has been proposed to be a heterodimeric protomer 
(a-B)2 (Brotherus et al., 1983; Fambrough et al., 1994). 
Thus far four a ,  and three B subunit isoforms of Na+, 
K+-AlTase have been identified in mammals (Martín- 
Vasallo et al., 1989; Shamraj and Lingrel, 1994; Malik et 
al., 1996). The al isoform serves as the 'housekeeping' 
isoform, as judged by its abundance and ubiquitous 
cellular distribution. It is believed to be the dominant a 
isoform in absorptive epithelia (Farman, 1996). The 
remaining isoforms exhibit restricted patterns of tissue 
Flg. 4. lmmunolocalization of Na+, K+-ATPase 01 and 02 isoforms in the human prostate gland. A and C. Low power light micrographs demonstrate 
abundant expression of 01 (A) and 02 (C) in epithelial cells. B and D. High power light micrographs demonstrate abundant expression of 01 (B) and 82 
@) in apical (indicated by black arrows) and lateral membranes (shown by white arrows) of epithelial cells. A, C, x 400; B, D, x 1,000 
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Fig. 5. Photomicrographs comparing relative immunolabeling of Na+, K+-ATPase al, a2 and a3 in the human prostate gland. The al isoform was 
expressed abundantly in the epithelial cells (A) but no staining was obse~ed  for a2 (B) and a3 (C) in the epithelial cells. x 1,000 
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specificity and developmental expression (Mobasheri et 
al., 2000). The a 2  isoform is expressed most abundantly 
in cardiac muscle, skeletal muscle and adipose tissue 
(Sweadner et al., 1994). The a3 isoform is found in high 
concentrations in neuronal cells in the central nervous 
system (Sweadner, 1995). The a 4  isoform appears to be 
speciñc to the testis (Shamraj and Lingrel, 1994). The B 1  
isoform is ubiquitously expressed whereas 82  appears to 
be concentrated in nervous tissue (Martín-Vasallo et al., 
1989; Lecuona et al., 1996; Peng et al., 1997); B2 is an 
adhesion molecule on glial cells (AMOG) specifically 
involved in mediating interactions between neuronal 
cells and glia (Gloor et al., 1990). The B3 isoform is the 
most recently described member of the B isoform gene 
family and is expressed predominantly in testis but also 
in the brain, kidney, lung, spleen, liver and intestines 
(Malik et al., 1996; Arystarkhova and Sweadner, 1997; 
Peng et al., 1997). 
Uptake and accumulation of citrate precursors such 
as aspartic acid by the prostate epithelium have been 
shown to be Na+ dependent and abolished by ouabain 
treatment (Lao et al., 1993), which also has dramatic 
effects on the vascular tone of the prostate (Guh et al., 
1996). Thus, Na+-dependent aspartate transport and 
subsequent metabolic steps leading to citrate secretion 
critically depend on the activity of Na+, K+-ATPase. 
Although much is known about amino acid transport and 
metabolism in the prostate (Franklin et al., 1990; Lao et 
Fig. 6. Evidence for expression of a l ,  81 and 82 isoforms of Na+, K+-ATPase in human prostate. PCR using human a and B isoform specific primers 
(Mobasheri et al., 1997; Stengelin and Hoifman, 1997; sea tables 2 and 3) established the presence of a l ,  81 and 82 and the absence of a2, a3, a4 
and 83 mRNA. A. Using oligonucleotide primer sets originally developed by Stengelin and Hofíman (1 997) PCR products of approximately 530 bp, 441 
bp and 455 bp corresponding to a l ,  81 and 82 were amplied from a prostate cDNA library. Expected products of 540 bp and 414 bp corresponding to 
a3 and 03 were not detected. B. In a separate experiment using oligonucleotide primers originally described by Mobasheri et al. (1997),a 349 bp PCR 
product corresponding to the a l  isoform was detected in the hurnan prostate cDNA library but products corresponding to a2, a3 and a4 were not 
detected. In al1 PCR experiments expression of 8-acün (310 bp product) was used as interna1 positwe control. 
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al., 1993), less is known about Na+, K+-ATPase. Reports 
of Na+, K+-ATPase function in the human prostate gland 
have been limited to biochemical and pharmacological 
studies (Wilson and Villee, 1975; Hirano et al., 1994). It 
has been hypothesized that Na+, Kt-ATPase may serve 
as a plasma membrane receptor for androgen in the fully 
developed prostate where its hormonal activation serves 
as a metabolic pacemaker (Farnsworth, 1990, 1993). 
However, no one has been able to provide any 
experimental data to support this hypothesis so  far. 
Recent in vitro studies employing prostate cancer cell 
lines have demonstrated that expression of the B1 subunit 
of Nat, Kt-ATPase is androgen responsive and both D 1  
mRNA and protein are down-regulated in its presence 
(Blok et al., 1998, 1999). Thus, there is indirect evidence 
that androgen influences Na+, K+-ATPase expression. 
Despite the insensitivity of Na+, Kt-ATPase al subunit 
expression to androgen in prostate cancer cell lines the 
plasma membrane density of the enzyme complex 
appears to be significantly down-regulated in the 
presence of androgen indicating regulation of this 
transport system by androgen (Blok et al., 1999). It has 
also been proposed that Nat, K+-ATPase is involved in 
regulating an important physiological function of the 
prostate gland, namely citrate synthesis and secretion, a 
Na+ dependent process (Farnsworth, 1993). Therefore, 
Na+, Kt-ATPase plays a pivotal role in the normal 
physiology of the prostate gland by generating steep 
transmembrane concentration gradients for Na+ that is 
utilized by a variety of other Na+ dependent transport 
systems for the Na+ dependent uptake of metabolites 
(amino acids and sugars; Rossier et al., 1987), regulation 
of prostatic fluid pH and control of citrate secretion. 
Thus far, evidence for the expression and localization of 
BASOLATERAL 
MEMBRANE 
LATERAL MEMBRANE 
llGHT/GAP JUNCTlONS 
Flg. 7. Model of physiological ion transport 
in the prostate secretory epithelium. This 
proposeti model is a revision of the original 
model proposed by Farnsworth (1993). 
The new model incorporates the data of 
Franklin et al. (199O), Lao et al. (1993), the 
data presented in this study as weil as 
some of our unpublished observations. 
Glycolysis and oxidative phosphorylation 
provide the ATP required by ATPase 
pumps. The molecular compocition of the 
individual transport proteins shown, and 
their membrane localization, is based on 
data presented in this article and 
unpublished immunohistochemical data. 
The proposed model places Na+, K+- 
ATPase consisting of allí31 and a1102 
isozymes predominantly in the apical 
membrane domains where their function is 
determined by the intracellular Na+:K+ Pí?osiATE raüo, transmembrane gradients of Na+ and 
 EN K+ and ultimately availability of intracellular 
ATP (Farnsworth, 1991, 1993). The 
presence of Na+ dependent aspartate 
transport systems and the cation 
exchangers (NHE) in basolateral and 
apical membrane domains of secretory 
epithelial cells (Franklin et al., 1990; Lao et 
al., 1993) identiies major entry routes for 
Na+. Na+/Ca2+ (NCX) exchanger and 
Na+IK+ICI- (NKCC) co-transporter 
mechanisms represent two alternative 
entry routes for Na+ also involved in 
intracellular Ca2+ regulation and volume 
homeostasis respectively. The identles of 
the citrate transporter(s) in the apical 
membrane and the glucose transporter(s) 
in the basolateral membrane are not 
known. Na+, K+-ATPase in the apical 
membrane is abundantly expressed and is 
responsible for acüve ejection of Na+ ions 
that gain access to the prostate cell 
cytoplasm via Na+ dependent transport 
mechanisms shown and others that 
remain to be identiied. 
LAMiAL MEMBRANE 
M / G A P  JüNCTK)NS 
Na+, K+-ATPase expression in human prostate 
Na+, K+-ATPase in specific membrane domains of 
prostatic epithelial cells has been indirect and anecdotal. 
Based on biochemical data, Lao and co-workers (1993) 
and Farnsworth (1993) have suggested that Na+, Kt- 
ATPase is localized in the apical membrane of the 
columnar epithelial cells in the prostate. Although the 
apical localization of Na+, K+-ATPase perfectly fits the 
plasma membrane receptor model of prostatic secretory 
function proposed by Farnsworth (1993; see Fig. 7), no 
immunohistochemical evidence has been provided to 
support this notion until now. To our knowledge there 
are no published reports of the cellular localization, 
molecular composition and isoform distribution of Na+, 
K+-ATPase in the human prostate gland. Therefore, we 
employed a well-characterized panel of isoform specific 
antibodies to unambiguously identify the domain 
localization of prostatic Na+, K+-ATPase, and its 
isoform composition and relative abundance. 
Expression of the catalytic al isoform and the 
regulatory B 1  and B2 isoforms suggests that the 
system may be composed of al-B1 and a l - B 2  
isozymes. Previous evidence for the domination of al 
containing Na+, K+-ATPase complexes comes from 
pharmacological studies in which M ouabain has 
been shown to inhibit less than 30% of Na+, K+-ATPase 
enzyme activity (Hirano et al., 1994). Thus, 70% or 
more of the enzyme activity remains suggesting that the 
prostatic Na+, K+-ATPase is relatively resistant to 
ouabain. This high leve1 of insensitivity to ouabain is 
indirect evidence for the dominance of al isoforms. 
Thus, based on this collateral evidence, it is unlikely that 
prostatic Na+, K+-ATPase contains ouabain sensitive a 2  
and a 3  isoforms characteristic of excitable tissues 
(Jewell and Lingrel, 1991). Our immuno-histochemical 
data support this notion. Furthermore, the polymerase 
chain reaction provides firm evidence for the presence of 
transcripts encoding al and the absence of mRNA for 
a 2  and a 3  from normal human prostate. 
Interestingly, the al-Bl complex is  the most 
ubiquitous combination and contributes significantly to 
Na+ reabsorption in absorptive epithelia such as kidney 
where Na+, K+-ATPase is confined to the basolateral 
membrane of cells lining the proximal tubule (Farman, 
1996). Thus, dominance of al expression in the prostate 
was expected as this isozyme combination is ubiquitous 
(Mobasheri et al., 2000). The apical/lateral Na+, K+- 
ATPase cannot be involved in Na+ reabsorption in the 
prostate. It is far more likely that it regulates the 
concentration of lumenal Na+ and K+ ions. Indeed, 
reports of Na+, K+-ATPase expression in other secretory 
epithelia have shown a particularly enhanced expression 
of B subunit isoforms of Na+, K+-ATPase in apical 
membranes of cuboidal cells of the choroid plexus and 
the ampullary crests of the inner ear's semicircular ducts 
(González-Martínez et al., 1994).  Smith (1969) 
demonstrated that Na+ and Kt are dominant counter- 
ions for secreted citrate in prostatic fluid; thus it may be 
speculated that apical Na+, K+-ATPase finely regulates 
the concentration of counter-ions according to the citrate 
levels present in prostatic fluid. Nat, K+-ATPase in 
lateral membrane domains probably plays a 
housekeeping homeostatic role. This model fits with a 
number of previous studies that have reported the range 
of ion concentrations found in prostatic and seminal 
fluids. Sodium (153 mM), potassium (48 mM) and 
chloride (38  mM) have been reported for normal 
prostatic fluid (Huggins et al., 1942) although the range 
of ion concentrations may vary widely according to age, 
secretory activity or the presence of prostatic disease 
(Kavanagh, 1985). Of particular importance is the 
finding that increased prostatic citrate secretion is 
accompanied by increased concentrations of Na+, Kt, 
ca2+, and ~ n 3 + ,  and by decreased C1- (Kavanagh, 
1985). Citrate will have low membrane permeability so 
that its secretion results in movement of diffusible ions 
to maintain the new Donnan equilibrium conditions. 
Citrate has a high affinity for the divalent cations ca2+, 
~ ~ 2 +  and ~ n 3 +(Sillen and Martel, 1971), which may be 
expected to be co-transported across the prostate 
secretory epithelium as a citrate complex. However, this 
is unlikely for unbound Na+ and Kt ,  whose 
concentrations are tightly regulated in prostatic 
secretions, and likely to be achieved by the specific 
action of Na+, K+-ATPase and other ion transport 
mechanisms (Le. epithelial Na+ channels, K+ channels, 
Na+/Kt/2Cl- co-transporter, Na+M+ exchanger) some of 
which are present in prostate epithelial cells (Mobasheri, 
unpublished observations). 
Polarized expression of a l ,  í31 and B2 isoforms to 
apical and lateral membranes of prostatic epithelial cells 
would suggest a specific role in contrast to many other 
absorptive epithelia in which Na+, K+-ATPase is 
primarily targeted to basolateral membrane domains. 
Furthermore, apical localization of the Na+, K+-ATPase 
is concordant with the role of prostatic epithelial cells in 
prostatic fluid production: ouabain-sensitive Na+, K+- 
ATPase-mediated transport is implicated in prostatic 
fluid formation since Na+ and K+ are major counter-ions 
for citrate which, together with C1-, represent a large 
component of prostatic fluid osmolarity (Smith, 1969). 
Our immunohistochemical observations taken together 
with other published information allows us to propose a 
revision of the prostate plasma membrane receptor 
model originally proposed by Farnsworth (1993). In the 
new model, active Na+, K+-ATPase located in apical and 
lateral membrane domains of prostatic epithelial cells 
maintain an inwardly directed Na+ gradient essential for 
uptake of aspartate (and other nutrients) as well as 
secretion of citrate (Fig. 7). Na+, K+-ATPase probably 
regulates the concentration of lumenal Na+ and K+, 
major counter-ions for citrate. Although the molecular 
identity of other transport systems responsible for 
reabsorption of excess counter-ions from the prostate 
lumen remains unknown, preliminary data (Mobasheri, 
A., unpublished data) suggest that the Na+/K+/2Cl- co- 
transporter and Na+/H+ exchanger are likely to be 
involved. 
It is clear that the plasma membrane is the most 
Na+, K+-ATPase expression in human prostate 
obvious target for drugs. Identification of ion transport 
systems involved in the process of cellular proliferation 
may enhance the strategy for future pharmacological 
intervention aimed at suppressing accelerated 
proliferation of prostate cells observed with aging in 
benign prostatic hyperplasia and invasive carcinomas of 
the prostate. This is particularly consistent with recent 
observations of Laniado et al. (1997) and Smith et al. 
(1998) demonstrating that voltage activated Nat 
channels are upregulated in highly metastatic cells 
derived from invasive carcinomas of the prostate and that 
inhibition of these Na+ channels with highly specific 
natural toxins abolishes invasive behavior in vitro. Ion 
channel expression is altered during neoplastic 
transformation (Caffrey et al., 1987) and this will affect 
the expression and abundance of other transport systems. 
Future studies in this area will be aimed at identification 
of Na+, K+-ATPase isozymes and other Na+ dependent 
transport systems in human prostate cancer. Where ion 
transport systems play indispensable physiological 
functions in the prostate, existing or novel 
pharmacological agents may target them making it 
possible to control and thus modulate the biosynthetic 
activity and proliferative capability of prostate cells 
(Foster et al., 1999). Therefore, our results suggest that 
Nat, K+-ATPase plays a key role in ion homeostasis in 
the prostate gland. Whether Na+, K+-ATPase is an active 
or passive participant in pathologies of the prostate gland 
or male infertility in general,  remain open but 
challenging questions. 
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